273 related articles for article (PubMed ID: 14551273)
1. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors.
Lu DS; Raman SS; Limanond P; Aziz D; Economou J; Busuttil R; Sayre J
J Vasc Interv Radiol; 2003 Oct; 14(10):1267-74. PubMed ID: 14551273
[TBL] [Abstract][Full Text] [Related]
2. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes.
Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
Radiology; 2014 Mar; 270(3):888-99. PubMed ID: 24475820
[TBL] [Abstract][Full Text] [Related]
3. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
[TBL] [Abstract][Full Text] [Related]
5. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy.
Valls C; Ramos E; Leiva D; Ruiz S; Martinez L; Rafecas A
Scand J Surg; 2015 Sep; 104(3):169-75. PubMed ID: 25332220
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation.
Schindera ST; Nelson RC; DeLong DM; Clary B
J Vasc Interv Radiol; 2006 Oct; 17(10):1631-7. PubMed ID: 17057005
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system.
Weisbrod AJ; Atwell TD; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
J Vasc Interv Radiol; 2007 Dec; 18(12):1528-32. PubMed ID: 18057287
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors.
Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W
J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
14. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
[TBL] [Abstract][Full Text] [Related]
17. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors.
Jiao LR; Hansen PD; Havlik R; Mitry RR; Pignatelli M; Habib N
Am J Surg; 1999 Apr; 177(4):303-6. PubMed ID: 10326848
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategy to optimize radiofrequency ablation for liver malignancies.
Chen MH; Wei Y; Yan K; Gao W; Dai Y; Huo L; Yin SS; Zhang H; Poon RT
J Vasc Interv Radiol; 2006 Apr; 17(4):671-83. PubMed ID: 16614151
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
20. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
